Search
Now showing items 1-3 of 3
Paul Harrison—investigating the psychiatric sequelae of COVID-19
(2022-04)
Paul Harrison describes his academic career as being low profile until several large studies on the psychiatric effects of COVID-19, including those linked to so called long-COVID, thrust him and his team into the limelight. ...
Exposure to phenytoin associates with a lower risk of post-COVID cognitive deficits: a cohort study
(2022-08)
Post-COVID cognitive deficits (often referred to as ‘brain fog’) are common and have large impacts on patients’ level of functioning.
No specific intervention exists to mitigate this burden.
This study tested the hypothesis, ...
Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients
(2022-08)
COVID-19 is associated with increased risks of neurological and psychiatric sequelae in the weeks and months thereafter. How long these risks remain, whether they affect children and adults similarly, and whether SARS-CoV-2 ...